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Abstract Second messenger-induced Ca
2+-release from
intracellular stores plays a key role in a multitude
of physiological processes. In addition to 1,4,5-inositol
trisphosphate (IP3), Ca
2+, and cyclic ADP ribose (cADPR)
that trigger Ca
2+-release from the endoplasmatic reticulum
(ER), nicotinic acid adenine dinucleotide phosphate
(NAADP) has been identified as a cellular metabolite that
mediates Ca
2+-release from lysosomal stores. While
NAADP-induced Ca
2+-release has been found in many
tissues and cell types, the molecular identity of the channel
(s) conferring this release remained elusive so far. Here, we
show that TPCN2, a novel member of the two-pore cation
channel family, displays the basic properties of native
NAADP-dependent Ca
2+-release channels. TPCN2 tran-
scripts are widely expressed in the body and encode a
lysosomal protein forming homomers. TPCN2 mediates
intracellular Ca
2+-release after activation with low-
nanomolar concentrations of NAADP while it is desensitized
by micromolar concentrations of this second messenger and
is insensitive to the NAADP analog nicotinamide adenine
dinucleotide phosphate (NADP). Furthermore, TPCN2-
mediated Ca
2+-release is almost completely abolished when
the capacity of lysosomes for storing Ca
2+ is pharmacolog-
ically blocked. By contrast, TPCN2-specific Ca
2+-release is
unaffected by emptying ER-based Ca
2+ stores. In conclusion,
these findings indicate that TPCN2 is a major component of
the long-sought lysosomal NAADP-dependent Ca
2+-release
channel.
Keywords TPCN2.Two-porechannels.NAADP.
Ca
2+-release.Lysosome.Acidicstores
Introduction
Ca
2+-release from intracellular stores is a fundamental
cellular process that is involved in the control of numerous
physiological functions including muscle contraction,
secretion, cell motility, and control of immune response
[3, 11]. Given the diversity and complexity of these
processes, it does not come as a surprise that Ca
2+-release
is controlled by a complex array of signaling pathways and
second messengers [19, 23, 29, 32]. NAADP is the latest
entry in the list of Ca
2+-releasing molecules [19, 20]. This
molecule is synthesized in the cell by ADP cyclases by
exchanging the nicotinamide moiety of NADP with
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2+-
releasing agents, NAADP is the most potent one acting in
the low-nanomolar concentration range [14]. The Ca
2+-
releasing activity of NAADP was first discovered in the
mid-1990s in acidic lysosome-related organelles of sea
urchin eggs [20] and has since been demonstrated in many
mammalian tissues and cell types [13, 17]. NAADP-
mediated Ca
2+-release is characterized by a number of
characteristic features. First of all, NAADP-dependent
Ca
2+-release displays a characteristic bell-shaped dose-
response curve with a peak in the low nanomolar
concentration range and total loss of activity at high
micromolar concentrations [8, 22]. Moreover, the native
NAADP-dependent Ca
2+-release channel is insensitive to
NADP which differs from NAADP only by the replacement
of a carboxyl by an amid group [15]. Finally, in contrast to
IP3- and Ca
2+/cADPR-sensitive stores, NAADP mainly
seems to induce Ca
2+-release from acidic lysosomal stores
[10, 13], although in some cell types, NAADP-mediated
Ca
2+-release was also found in ER-derived stores, including
the nuclear envelope [15]
The molecular identity of the cellular NAADP receptor
has been a matter of controversy [13, 17]. It was suggested
that there may be no unique receptor for NAADP but that
NAADP, like Ca
2+ and cADPR, is an agonist of the
ryanodine receptor (RyR) complex present in ER-derived
calcium stores [15]. Other studies suggested that members
of the transient receptor potential (TRP) channel family
including TRPM2 [1] and TRPML1 [34] may be the cellular
target protein of NAADP. However, the micromolar
concentrations of NAADP required to fully activate these
channel are one to two orders higher than those found for
NAADP-mediated Ca
2+-release in a variety of cells. Since
none of the so-far analyzed proteins matches the hallmarks
of native NAADP-sensitive release channels in a satisfying
fashion, we hypothesized that the major receptor of NAADP
may be formed by another not yet characterized protein.
Materials and methods
Cloning of TPCN1 and TPCN2
For cloning of TPCN1, two cDNA fragments were
amplified from mouse brain RNA by RT-PCR using the
SuperScript III-One-Step Kit (Invitrogen; primers for
fragment 1: TTA GAA ATG CCT CTG ATG GAA and
ATG CTT TGA GGT GAA ATT CCC A; primers for
fragment 2: CAG ACA GCA TTG GTT TGA TGA G and
GTG GGG TTT CTT CCT AGT GGT CTC GAG CCT
CAT ACC AGA CAC AGA CAC). Following restriction
digests, the two fragments were assembled in pcDNA3
using the Hind III site in the 5′ untranslated region, the
central EcoR I site, and the Xho I site generated by PCR in
the 3′ untranslated region (fragment 1=1,413 bp, fragment
2=1,548 bp). For cloning of TPCN2, the complete open-
reading frame was amplified from mouse brain RNA. The
forward primer (GGC TGT GGT ACC GCC ACC ATG
GCG GCA GAA GAG CAG C) binds to the 5′ end and
contains a Kozak consensus sequence and a Kpn I
restriction site for cloning; the reverse Primer (GCC GCT
CGA GAG GCC AGC ATC TCT GTC CTG) binds to the
3′ untranslated region and contains a Xho I restriction site
for cloning. After restriction digest with KpnI and XhoI, the
2,255-bp fragment was cloned into pcDNA3 vector
(Invitrogen). All cloned sequences were verified by
sequencing.
Northern blot
A mouse multiple tissue Northern blot (Applied Biosystems/
Ambion, Austin, TX) containing 2 µg poly(A) RNA from
heart, brain, liver, spleen, kidney, lung, thymus, testis, ovary,
and embryo was hybridized with probes against TPCN1 and
TPCN2. Probes covered the entire coding regions and were
generated by random-primed labeling with a α
32P-dCTP
(Roche, Basel, Switzerland). The membrane was hybridized
overnight in stringent conditions. After two washing steps,
the hybridized probe was visualized with a phosphorimager
after an exposure time of 24 h or using a film (Hyperfilm
MP, GE Healthcare, Piscataway, NJ) after a radiographic
exposure time of 14 days at –80°C. The same blot was
probed subsequently with TPCN1 and TPCN2 probes. The
blot was stripped between each hybridization with SDS-
containing buffer.
Production of TPCN2-specific antibodies
Polyclonal rabbit antisera were raised against a peptide
(CDILE EPKEE ELMEK LHKHP) corresponding to aa
707 to 725 of TPCN2 plus a N-terminal cystein. For
affinity purification of antibodies, the peptide was coupled
to SulfoLink Coupling Gel (Thermo Fisher Scientific,
Walthan, USA) in a column. Serum was loaded onto
column and washed. Bound antibodies were eluted with
100 mM Glycin-HCl pH 2.8 in 800 µl aliquots and
immediately neutralized with Tris-base.
Deglycosylation assay
The glycosylation deficient TPCN2 mutant (N594Q/N601Q)
was cloned using the QuickChange Kit (Stratagene, La Jolla,
CA). The deglycosylation assay was performed as described
previously [25]. Briefly, HEK293 cells were transfected
with TPCN2, TPCN2N594Q/N601Q, or EGFP-TPCN1
using the calcium phosphate method and lysed; 10 µg of
892 Pflugers Arch - Eur J Physiol (2009) 458:891–899whole-cell lysates were incubated in the presence or
absence of PNGase F or endoglycosidase H (both New
England Biolabs, Ipswich, MA), according to the manu-
facturer’s instruction. The protein denaturation was per-
formed for 10 min at 45°C, the enzyme incubation for 1 h
at 37°C. Cell lysates were then analyzed. Subsequently,
proteins were subjected to Western blot analysis.
Coimmunoprecipitation in HEK293 cells
For coimmunoprecipitation experiments, TPCN2 and TPCN1
fusionproteinsweregeneratedwitheithermyctagfusedatthe
N-terminus or with EGFP sequence fused at the N-terminus.
For expression of recombinant proteins, HEK293 cells were
transfected using the calcium phosphate method. Three days
after transfection, HEK293 cells were lysed as described
previously [30]. Equal amounts of protein (measured by
Bradford assay) were incubated overnight at 4°C with 40 µl
of protein A-Sepharose (GE Healthcare, Chalfont St. Giles,
UK) and a specific antibody (Cell Signaling Technology,
Beverly, MA) directed against the myc tag of examined
proteins and 500 µl of buffer containing 50 mM Tris HCl
(pH 7.4), 150 mM NaCl, 1 mM EDTA, and 50 mM Triton
X-100, supplemented with PI. Beads were pelleted by
centrifugation and washed three times with cold buffer
containing 20 mM Tris HCl (pH 7.4), 5 mM MgCl2,0 . 5m M
DTT, 20% (v/v) Glycerol supplemented with PI. Interacting
proteins were visualized after boiling for 5 min in Laemmli
sample buffer by SDS/PAGE, Western blot analysis, and
ECL (GE Healthcare). The antibodies used were as follows:
anti-GFP for detection of EGFP-TPCN2 fusion protein. An
antibody against GST (GE Healthcare) was used as control.
Immunocytochemistry
For immunodetection, COS-7 cells grown on glass
coverslips in a 24-well plate were transiently transfected
with TPCN2 cDNA using Fugene 6 (Roche Diagnostics).
Cells were cultured in DMEM supplemented with 10%
fetal calf serum and kept at 37°C, 10% CO2 and fixed 1
or 2 days after transfection with 4% paraformaldehyde in
PBS. Cells were permeabilized and blocked with 0.5%
Triton X-100 and 5% Chemiblock (Millipore, Billerica,
USA) in PBS. Cells were incubated with anti-TPCN2
(1:1000), anti-Myc (Cell Signaling, Danvers, MA;
1:1,000), anti-GFP (Clontech, Mountain View, USA;
1:500), anti-HA (Cell Signaling; 1:1000), anti-lamp1
(Abcam, Cambridge, USA; 1:250), and anti-Calnexin
(Santa Cruz Biotechnology, Santa Cruz, USA; 1:100)
primary antibodies in 2% Chemiblock (Millipore) and
0.3% Triton X-100 for 1 h. Then, cells were washed four
times with PBS for 5 min each and incubated with AMCA
(1:100), Cy2 (1:200), Cy3 (1:400), and Cy5 (1:400)
secondary antibodies (all Jackson ImmunoResearch, West
Grove, PA) in 2% Chemiblock (Millipore) for 1 h.
Unbound antibodies were removed by three washing steps
with PBS. For the staining of membranes and organelles,
TRITC-WGA (membranes; 1:100; Sigma), Mitotracker
Red CMX Ros (Mitochondria; 1:1,500; Invitrogen), and
Hoechst 33342 (Nuclei; 0.4 µg/ml; Invitrogen) were used
according to manufacturers’ instructions. For visualization
of lysosomes, in some experiments, a lamp1-EGFP fusion
p r o t e i nw a sc o - e x p r e s s e dw i t hT P C N 2( k i n dg i f to f
Esteban C. Dell'Angelica, Dept Human Genetics, UCLA,
USA). The glass coverslips were then mounted onto glass
slides with Permafluor (Sigma, St. Louis, MO). Cells were
visualized under a Zeiss LSM 510 laser confocal micro-
scope as previously described [25].
Cell surface expression
To determine surface expression of TPCN2 in COS-7 cells,
the HA epitope was inserted into the loop between the
putative first and second transmembrane domains of
TPCN2. Two mutagenic primers (GTC GGG AAC ATC
GTATGG GTA AGT CTT TGT GAA GGA AGA TGG G
and TAC GAT GTT CCC GAC TAC GCA GAT GTG
CGC TAC CGT TC) have been used to insert the
hemagglutinin sequence (YPYDVPDYA) in frame between
amino acid residues 92 and 93 of TPCN2 using the
QuikChange Kit (Stratagene) according to the manufac-
turer’s instruction. The sequence has been verified by
sequencing. After transfection, cells were analyzed by
immunocytochemistry as described above except for
omitting the permeabilization step with Triton X-100
(nonpermeabilized cells). Control cells were treated equally
but permeabilized.
Ca
2+ imaging
Two days after transfection with TPCN2-EGFP or with the
empty EGFP vector using Fugene 6 (Roche, Basel,
Switzerland), HEK293 cells were loaded with Fura-2AM
(5 µM) before measuring [Ca
2+]i and subsequently placed
in extracellular recording solution containing (in mM) 140
NaCl, 5 KCl, 3 MgCl2, 10 glucose, and 10 HEPES, pH 7.4.
The fluorescence intensity of individual patch-clamped
cells was monitored with a dual excitation fluorometric
system using a Carl Zeiss Axiovert 135 fluorescence
microscope equipped with a ×40 Plan-Apochromat 1.3 oil
objective. The monochromatic light source (Polychrom II,
TILL-Photonics) was tuned to excite Fura-2 fluorescence at
340 nm (F340) and 380 nm (F380) with a sampling
frequency of 0.5 Hz for 3 ms each. Emission was detected
at 450–550 nm using a PCO SensiCam VGA camera
(Kelheim, Germany) and recorded and analyzed using
Pflugers Arch - Eur J Physiol (2009) 458:891–899 893Tillvision (Till Photonics, Martinsried, Germany). For
internal perfusion with NAADP, NADP, or IP3, Fura-
2AM-loaded HEK293 cells were patched in standard
whole-cell configuration. After establishing base line [Ca
2+]i,
the membrane was perforated, and the recording was
c o n t i n u e di nc u r r e n tc l a m pm o d e( I=0) [4]. Patch pipette
solution contained in mM—1 4 0K C l ,1 0H E P E S ,1M g C l 2,
and 0.05 BAPTA (pH 7.4) [6]. Fura-2 (pentapotassium salt,
Invitrogen, Carlsbad, USA) was added to the standard
internal solution at 7 µM in addition to preloading. Changes
in Fura-2 fluorescence are reported as the fluorescence ratios
(F340/F380) and are translated into apparent intracellular
calcium concentration according to [16].
Statistics
All values are given as mean±SEM; n is the number of
experiments. An unpaired t test was performed for the
comparison between two groups. Significance was tested
by ANOVA followed by Dunett test if multiple compar-
isons were made. Values of P<0.05 were considered
significant.
Results
In our search for novel intracellular Ca
2+-release channels,
we analyzed mammalian homologs of the two-pore cation
channel TPC1, a Ca
2+-activated release channel identified
in the vacuolar membrane of Arabidopsis thaliana and other
plants [26]. A rat homolog of TPC1, designated TPCN1
was originally cloned from rat kidney but was not
functionally characterized [18]. Based on sequence data
from the gene bank, we cloned full-length murine TPCN1
and a novel homolog of this channel, TPCN2. Murine
TPCN1 and TPCN2 show an overall sequence identity of
about 20% to each other and to plant TPC1 [26] (Fig. 1a,
Supplementary Fig. S1). TPCN channels represent a
distinct branch within the superfamily of pore-loop chan-
nels [12, 31]. They are composed of two homologous
building blocks each containing six transmembrane helices
(S1–S6) and an ion-conducting pore loop between S5 and
S6. The two putative pore loops of TPCN1 and TPCN2
show substantial homology to the pore of TPC1. In contrast
to TPC1 both murine channels do not contain EF hand
Fig. 1 Properties of two-pore channels. a Upper panel Transmembrane
topology of TPCN1 and TPCN2. The predicted N-glycosylation sites
are marked by red forks. Lower panel Schematic representation of the
primary sequence of TPCN1 and TPCN2. The degree of sequence
identity within the N- and C-termini, the two transmembrane building
blocks and the interdomain linker is indicated. b Mouse multiple tissue
northern blots of TPCN1 (left panel) and TPCN2 (right panel)
demonstrate expression in all tissues investigated. c EGFP-TPCN1
(upper panel) and EGFP-TPCN2 (lower panel) channels expressed in
HEK293 cells are localized intracellularly (green TPCN channels; red
membrane marker, blue nuclei; scale bar 5µ m ) .d Western blots with
lysates from HEK293 cells containing myc-tagged TPCN1 (left panel),
wild-type TPCN2 (middle) panel, and a glycosylation-deficient TPCN2
double-mutant (TPCN-2Q; right panel). Ten micrograms of protein
were applied per lane. e Lysates of HEK293 cells cotransfected with
myc-tagged TPCN2 and EGFP-tagged TPCN2 (lanes 1–3)o r
myc-tagged TPCN1 and EGFP-tagged TPCN2 (lanes 6–8) were
immunoprecipitated with anti-myc antibody (lanes 2, 5, 7) or anti-
GST (control, lanes 3 and 8), blotted and probed with anti-GFP. Lanes
1, 6 input, lane 4 negative control
b
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2+ sensors in TPC1. Transcripts of
TPCN1 and TPCN2 are widely expressed in the body
(Fig. 1b, Supplementary Figs. S2,S 3) with expression
levels of TPCN1 usually being higher than those of TPCN2
(Fig. 1b, Supplementary Fig. S3). The size of the detected
mRNA transcripts corresponds well to the size of the
predicted sequence (4,705 bp for TPCN1 and 2,909 bp for
TPCN2). Upon heterologous expression in HEK293 or
COS-7 cells, both TPCN1 and TPCN2 are strictly localized
in intracellular compartments (Figs. 1c, 2). Removal of the
cytosolic N- and C-termini, as well as deletion of cryptic
ER retention signals [33], present in the primary sequences
of TPCN1 or TPCN2 (dileucine motifs starting at position
8 and 692 and a RxR motive starting at position 313 in
TPCN2) did not result in increased expression in the
plasma membrane (not shown). Two protein bands were
detected in immunoblots for either TPCN1 or TPCN2
(Fig. 1d, left lanes in left and middle panels, see also
Supplementary Fig. S4 for generation and validation of the
TPCN2 antibody). The respective lower bands represent the
core-glycosylated proteins since they are shifted to slightly
lower molecular weights after incubation with endo-
glycosidase H (EndoH). The upper band corresponds to
the fully glycosylated mature channel which is resistant to
Endo H and is sensitive to treatment with N-glycosidase F
(PNGase F). Mutation of the two putative N-glycosylation
sites in TPCN2 (N594 and N601) resulted in the production
of a non-glycosylated protein (Fig. 1d, right panel). The
size of the non-glycosylated TPCN1 and TPCN2 proteins
was smaller than predicted from the primary sequence (78.5
Fig. 2 TPCN2 is localized in the lysosomes. Immunocytochemistry
of TPCN2 in COS-7 cells. a Strong TPCN2 staining (green)i s
observed in intracellular compartments. By contrast, TPCN2 is absent
from the plasma membrane (visualized in red by a specific maker). b
After permeabilization, HA-tagged TPCN2 is detected intracellularily.
c HA-tagged TPCN2 is not detected in the membrane of non
permeabilized cells. d–f Colocalization of TPCN2 (green) and the
ER marker protein calnexin (red). Most TPCN2-positive structures (d)
costaine for endoplasmic reticulum (e), yielding yellow in the overlay
(f). g–i Colocalization of TPCN2 (green) and lamp1 (red). Most
TPCN2-positive structures (g) costained for lysosomes (h), yielding
yellow in the overlay (i). (bars 10 µm)
Pflugers Arch - Eur J Physiol (2009) 458:891–899 895vs. 94.3 kDa for TPCN1 and 63 vs. 83.5 kDa for TPCN2).
The apparent smaller molecular weight very likely arises
from an aberrant gel mobility of the two proteins because it
was also observed with EGFP-tagged TPCN channel
proteins and with antibodies that were targeted to either N-
or C-termini. Given the principal topology of pore-loop
cation channels, it is very likely that two TPCN channel
subunits assemble to form a complex with pseudo-tetrameric
symmetry. Indeed, co-immunoprecipitation experiments
showed that TPCN2 assembles with each other to form
homomers (Fig. 1e). By contrast, TPCN2 did not form
immunocomplexes with TPCN1 indicating that TPCN2–
TPCN1 heteromers are not formed in the cell (Fig. 1e).
We next analyzed the subcellular expression of heterol-
ogously expressed TPCN2 in COS-7 cells. Using wild-type
TPCN2 (Fig. 2a) and TPCN2 channels carrying a HA tag in
the linker region between S1 and S2 (Fig. 2b, c), we
confirmed that the channel is expressed purely in intracel-
lular compartments. Within the cell, TPCN2 was present in
the ER (Fig. 2d–f) and colocalized with the lysosomal-
associated membrane protein 1 (lamp1) that is a specific
marker for acidic lysosomes (Fig. 2g–i, Supplementary
Fig. S5). By contrast, there was no significant overlap
of the TPCN2 signal with a mitochondrial marker
(MitoTracker, Supplementary Fig. S6).
The presence of TPCN2 in the ER and in lysomomes
suggested that the protein may be a candidate for the
NAADP-sensitive release channel [10, 13, 15]. In order to
test this hypothesis, we measured calcium transients by using
Fura-2 fluoresence in HEK293 cells (Fig. 3). Fluorescence
was measured in the whole-cell patch-clamp configuration
with a Ca
2+-free extracellular solution to ensure that changes
in fluorescence were due to intracellular release. Cells
transfected with TPCN2 that was N-terminally fused with
EGFP to monitor expression (Supplementary Fig. S4)
showed a similar basal Ca
2+ concentration (62.9±21.4 nM;
n=15) as control cells transfected with EGFP alone (50.6±
19.5 nM; n=8). Intracellular application of 30 nM NAADP
produced a robust Ca
2+ transient in TPCN2-transfected cells
(Fig. 3a, c). The peak Ca
2+ concentration was 292±54.9 nM
(n=28) which is in excellent agreement with Ca
2+ concen-
trations obtained in native cells after stimulation by NAADP
[24, 28]. By contrast, control cells transfected with EGFP did
not respond to NAADP (P<0.001; Fig. 3b, upper trace).
Moreover, a close structural homolog of NAADP, NADP
[15] did not yield a Ca
2+ transient in TPCN2-transfected
cells (P<0.001; Fig. 3b, middle trace). Remarkably, cells
transfected with a TPCN1-EGFP fusion protein displayed no
NAADP-sensitive Ca
2+-release (P<0.001). The dose–
response curve of TPCN2 for NAADP has the typical bell-
shape described for the native mammalian release channel
[8, 22]( F i g .3d). The channel starts to get activated in the
low nanomolar range of NAADP, reaches a peak at about
30 nM and inactivated at higher concentrations of NAADP.
At micromolar NAADP concentrations, the channel is totally
inactive.
In HEK293 and COS-7 cells, TPCN2 was localized in
the ER and the lyosomes. We tested from which of these
compartments the observed Ca
2+-release was originating.
Preincubation of the cells with bafilomycin, a specific
Fig. 3 NAADP triggers Ca
2+-
release in HEK293 cells trans-
fected with TPCN2. Application
of 30 nM NAADP via the patch
pipette induces Ca
2+-release
from internal stores in cells
transfected with TPCN2-EGFP
(a) but not in cells transfected
with EGFP alone (b, upper
panel) or cells transfected with
TPCN1-EGFP (b, lower panel).
In cells transfected with
TPCN2-EGFP, NADP (30 nM;
negative control) did not induce
Ca
2+-release (b, middle panel).
The arrows in a, b indicate the
start of cell perfusion. c
Population data for experiments
performed in (a, b). d
Dose–response relationship of
NAADP. All values are given as
mean ± SEM. Number of cells
measured is indicated in
brackets in (c) and (d)
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+ ATPase [5], almost
completely abolished NAADP-mediated Ca
2+-release
(Fig. 4a, d). By contrast, when ER stores were depleted by
preincubation with the Ca
2+-ATPase inhibitor thapsigargin,
NAADP-sensitive Ca
2+-release was not significantly reduced
(Fig. 4b, d). IP3 which opens IP3Rs in the ER induced Ca
2+-
release in control cells but did not evoke Ca
2+ transients in
thapsigargin-pretreated cells (P<0.001), demonstrating that
the ER is functionally intact in TPCN2 expressing cells
(Fig. 4c, d). These findings indicate that the observed Ca
2+-
release in TPCN2 expressing cells arises from lysosomal
stores while the channel in the ER is functionally silent. The
reason for the lack of activity of the channel in the ER has to
be determined. However, one may speculate that TPCN2
requires an acidic pH as present in the lysomes and/or the
assembly with proteins specifically expressed in lysosomes
to acquire biological activity.
Discussion
Here, we show that TPCN2, a novel member of the two-
pore cation channel family, displays the basic functional
properties of the native NAADP-dependent Ca
2+-release
channel. TPCN2 transcripts are widely expressed in the
body and have been found in all tissues and organs
investigated. TPCN2 encodes a glycosylated 75 kD protein
forming homomers. Given the principal transmembrane
topology of pore-loop cation channels, it is very likely that
two TPCN channel subunits assemble with each other to
form a complex with pseudo-tetrameric symmetry. This
finding is in principal agreement with the reported
molecular mass of the NAADP receptor of approximately
120 kDa [2, 9] that roughly corresponds to a TPCN2 dimer.
The TPCN2 protein is specifically localized in intracellular
compartments and is totally absent from the plasma
membrane. Within the cells, the protein was present in
acidic lysosomes and in the ER. Since our functional
studies strongly indicate that only the lysosomal fraction of
TPCN2 is sensitive to NAADP, the presence of TPCN2 in
the ER probably reflects an overexpression phenomenon, as
reported for other proteins, including ion channels [27].
Several lines of evidence support the notion that TPCN2
is a key component of long-sought lysosomal NAADP
receptor. First of all, TPCN2 is the first channel identified
that responds to NAADP in the correct physiological
Fig. 4 TPCN2 mediates NAADP-dependent Ca
2+-release from
lysosomes. a In HEK293 cells transfected with TPCN2-EGFP,
preincubation (45 min) with 100 nM bafilomycin almost completely
abolished NAADP (30 nM)-induced Ca
2+-release (black line). Red
line control without pretreatment. b In HEK293 cells transfected with
TPCN2-EGFP, preincubation (15 min) with 1 µM thapsigargin did not
reduce NAADP-sensitive Ca
2+-release (black line). Red line same
control as in (a). c Effect of thapsigargin (1 µM) on the IP3 (3 µM)-
induced Ca
2+-release. Experiments were performed either with (black
line) or without (red line) thapsigargin preincubation (1 µM; 15 min).
Arrows in (a–c) indicate the start of cell perfusion. d Population data
for experiments shown in (a–c). Number of cells measured is
indicated in brackets. Tg thapsigargin; Baf bafilomycin; IP3 Inositol-
1,4,5-trisphosphate. Fluorescent ratio were normalized for better
comparison
Pflugers Arch - Eur J Physiol (2009) 458:891–899 897concentration range (low nM) [14]. Secondly, as described
for native channels, TPCN2 is inactivated by micromolar
NAADP concentrations [8, 22]. Thirdly, the channel is
insensitive to the NAADP homolog NADP [15]. Also, the
homologous TPCN1 channel is totally insensitive to
NAADP. Fourthly, the increase in the intracellular Ca
2+
concentration in cells expressing TPCN2 was in the same
range as described for native NAADP-release channels [24,
28]. Fifthly, TPCN2 is localized in the acidic lysosomes,
the subcelluar organelles where NAADP-dependent Ca
2+-
release was originally described [10]. Importantly, TPCN2
activity is abolished by maneuvers that deplete the
lysosomes [10, 13] indicating that the protein is fully
operative in these organelles. By contrast, TPCN2 present
in the ER was functionally silent. While we cannot exclude
that TPCN2 requires assembly with another cellular protein
to form a functional Ca
2+-release channel, the simplest
interpretation of our work is that TPCN2 itself forms the
lysosomal NAADP-sensitive Ca
2+-release channel. Further
in vivo studies will be required to dissect the signaling
cascades that control activation and modulation of TPCN2.
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